Calixto Machado | Clinical Neuroscience | Best Researcher Award

Published on by Neuroscientists

Prof. Dr. Calixto Machado | Clinical Neuroscience | Best Researcher Award

Prof. Dr. Calixto Machado | Institute of Neurology and Neurosurgery | Cuba

Calixto Machado is a Full Professor and Senior Researcher in Neurology and Clinical Neurophysiology at the Institute of Neurology and Neurosurgery in Havana, Cuba, and a Corresponding Fellow of the American Academy of Neurology. He completed his medical degree, followed by specialist training in neurology and clinical neurophysiology, and then earned his PhD. Over four decades he has led pioneering research on disorders of consciousness, brain death, stroke, autism, autonomic nervous system disorders and the neurological sequelae of SARS-CoV-2. He has published nearly 700 peer-reviewed journal articles, book chapters and authored seven books; his work is recognised internationally through numerous symposia and awards. His Google Scholar profile lists an h-index of 37, and over 24 000 citations across his published documents.

Profile: Google Scholar

Featured Publications:

Machado, C. (2025, September 9). Jahi McMath case: A comprehensive and updated narrative. World Journal of Critical Care Medicine, 14(3), 107513.

Machado, C. (2022). The Jahi McMath case: First detailed study of her brain. Neurology India, 70(5), 22–35.

Giacino, J. T., Ashwal, S., Childs, N., Cranford, R., Jennett, B., Katz, D. I., Kelly, J. P., & others. (2002). The minimally conscious state: Definition and diagnostic criteria. Neurology, 58(3), 349–353.

Sloan, M. A., Alexandrov, A. V., Tegeler, C. H., Spencer, M. P., Caplan, L. R., & others. (2004). Assessment: Transcranial Doppler ultrasonography report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology, 62(9), 1468–1481.

Machado, C. (2002). Brain death worldwide: Accepted fact but no global consensus in diagnostic criteria. Neurology.

Machado, C. (2007). Cerebral response to patient’s own name in the vegetative and minimally conscious states. Neurology, 69(7), 708.

Machado, C., Korein, J., Ferrer, Y., Portela, L., & others. (2007). The concept of brain death did not evolve to benefit organ transplants. Journal of Medical Ethics, 33, 197–200.

Machado, C. (2007). The concept of brain death did not evolve to benefit organ transplants. In C. Machado (Ed.), Brain death: A reappraisal (pp. 1–20). Springer.

Machado, C. (2007). Brain death: A reappraisal. Springer Science & Business Media.

Machado, C. (2007). The first organ transplant from a brain-dead donor. In C. Machado (Ed.), Brain death: A reappraisal (pp. 1–20). Springer.

Machado, C. (2010). Diagnosis of brain death. Neurology International, 2(1), e2.

Graf, W. D., Miller, G., Epstein, L. G., & Rapin, I. (2017). The autism “epidemic”: Ethical, legal, and social issues in a developmental spectrum disorder. Neurology, 88(14), 1371–1380.

Machado, C., Korein, J., Aubert, E., Bosch, J., Alvarez, M. A., Rodríguez, R., & others. (2007). Recognizing a mother’s voice in the persistent vegetative state. Clinical EEG and Neuroscience, 38(3), 124–126.

Lewis, A., Bernat, J. L., Blosser, S., Bonnie, R. J., Epstein, L. G., Hutchins, J., & others. (2018). An interdisciplinary response to contemporary concerns about brain death determination. Neurology, 90(9), 423–426.*

Kathrin Eichinger | Clinical Neuroscience | Outstanding Contribution Award

Published on by Neuroscientists

Dr. Kathrin Eichinger | Clinical Neuroscience | Outstanding Contribution Award 

Dr. Kathrin Eichinger | Medizinische Universitat Wien | Austria

Dr. Med. Kathrin Eichinger is an Austrian physician specializing in Pediatrics and Pediatric Neurology, currently serving as a Consultant in Child and Adolescent Medicine with subspecialty training in Neuropediatrics at the Medical University of Vienna. Her clinical and academic focus lies in neuroimmunology, with ongoing doctoral research in neuroscience examining acute necrotizing encephalitis. Dr. Eichinger’s experience spans several leading medical institutions, including Sankt Anna Children’s Hospital and the Hospital of the Brothers of Mercy in Eisenstadt, complemented by an observership in Neurointensive Care and Neuroimmunology at the Children’s Hospital of Philadelphia. She has also contributed to clinical research through her involvement in the eSMART randomized controlled trial on electronic symptom management at the Medical University of Vienna. Her expertise is further supported by certification in pediatric EEG and active participation in numerous neuropediatric congresses and workshops across Europe. Multilingual in German, English, and Spanish, Dr. Eichinger combines her clinical acumen with strong research engagement, reflected in her growing academic footprint with an h-index of 3, five peer-reviewed documents, and approximately 45 citations. Her professional pursuits integrate advanced clinical training, translational neuroscience, and a dedication to improving pediatric neurocare.

Profile: Orcid

Featured Publications

  • Eichinger, K., Breu, M., Renken, M., Siegert, S., Hilz, E., Glatter, S., Csaicsich, D., Boehm, M., Lechner, C., Kornek, B., et al. (2025). Complications of therapeutic plasma exchange in pediatric neuroimmune disorders. Children, 12(11), 1457.

  • Grasl, S., Janik, S., Dressler, A., Diehm, R., Gröppel, G., Eichinger, K., Grasl, M. C., Gstoettner, W., Feucht, M., Vyskocil, E., et al. (2021). Management and outcome of vagus nerve stimulator implantation: Experience of an otolaryngeal/neuropediatric cooperation. European Archives of Oto-Rhino-Laryngology, 278(10), 3729–3738.

Seyyed Ali Zendehbad | Clinical Neuroscience | Best Researcher Award

Published on by Neuroscientists

Dr. Seyyed Ali Zendehbad | Clinical Neuroscience | Best Researcher Award

Dr. Seyyed Ali | Zendehbad University of Mazandaran | Iran

Dr. Seyyed Ali Zendehbad is a multidisciplinary researcher specializing in biomedical signal processing, cognitive computational neuroscience, and neurorehabilitation technologies. His research integrates deep learning, pattern recognition, and multimodal biological data modeling to enhance fatigue detection and neurorehabilitation systems. He has authored several peer-reviewed papers in reputable journals such as Scientific Reports, IEEE Access, Sensing and Bio-Sensing Research, and Healthcare Technology Letters, focusing on hybrid AI frameworks, EMG signal processing, and muscle synergy-based biofeedback mechanisms. Dr. Zendehbad’s work on developing intelligent rehabilitation systems, including his models like TraxVBF and FatigueNet, contributes to advancing telemonitoring and assistive technologies for neurological recovery. His scholarly output includes more than 25 documents, over 600 citations, and an h-index of 12, reflecting his growing impact in computational neuroscience and biomedical engineering. Recognized for innovation, he has achieved first-place awards in multiple national startup competitions and was honored with the Best Poster Award at the Congress of Neurology and Clinical Electrophysiology of Iran. As a postdoctoral researcher at the University of Mazandaran, his ongoing work emphasizes integrating trustworthy AI into telehealth systems, promoting equitable and efficient digital healthcare delivery through interdisciplinary research and technological innovation.

Profile: Orcid

Featured Publications

1. Mazrooei Rad, E., Mazinani, S. M., & Zendehbad, S. A. (2025). Diagnosis of Alzheimer’s disease using non-linear features of ERP signals through a hybrid attention-based CNN-LSTM model. Computer Methods and Programs in Biomedicine Update, 5, 100192.

2. Zendehbad, S. A., Sharifi Razavi, A., Tabrizi, N., & Sedaghat, Z. (2025). A systematic review of artificial intelligence techniques based on electroencephalography analysis in the diagnosis of epilepsy disorders: A clinical perspective. Epilepsy Research, 207, 107582.

3. Mazrooei Rad, E., Zendehbad, S. A., & Hosseinzadeh, V. (2025). Fetal QRS complex detection based on adaptive filters and peak detection. Research on Biomedical Engineering, 41(3), 424–438.

4. Zendehbad, S. A., Ghasemi, J., & Samsami Khodadad, F. (2025). FatigueNet: A hybrid graph neural network and transformer framework for real-time multimodal fatigue detection. Scientific Reports, 15(1), 640.

5. Safdel, A., Zendehbad, S. A., & Ghasemi, J. (2025). Advanced deep learning approaches for accurate and efficient suspicious behavior detection in surveillance videos. Computational Sciences and Engineering, 21(2), 1099.

Maria -Camelia Stancioaica | Clinical Neuroscience |

Published on by Neuroscientists

Ms. Maria -Camelia Stancioaica | Clinical Neuroscience | Best Researcher Award

Ms. Maria -Camelia Stancioaica | Fundeni Clinical Hospital | Romania

Dr. Maria Camelia Stăncioaica is a dedicated Romanian hematologist affiliated with the Fundeni Clinical Institute in Bucharest, where she serves as the Acute Leukemia Program Coordinator. She holds an M.D. in Clinical Hematology and is currently pursuing her Ph.D. at the Carol Davila University of Medicine. Her professional development includes international experience through observership at Johns Hopkins Hospital in the USA and an internship at Pitié–Salpêtrière Hospital in France. Dr. Stăncioaica has contributed to advancing hematologic research through publications addressing acute leukemia, fungal infections in immunocompromised patients, and targeted therapies in acute myeloid leukemia. Her notable works include studies on FLT3 inhibitors, differentiation syndrome in pregnancy, and invasive fusariosis outbreaks. Actively engaged in global scientific dialogue, she has been a speaker and session chair at prominent hematology conferences across Europe. She also participates in several clinical trials as both principal and subinvestigator, focusing on novel therapeutic strategies in leukemia management. Dr. Stăncioaica’s research achievements are reflected in her 21 citations, 2 h-index, and 1 i10-index, underscoring her growing influence in clinical hematology. She is a member of the European Hematology Association and the Romanian Society of Hematology, contributing to both national and international medical communities.

Profile: Google Scholar

Featured Publications

1. Ghiaur, A., Doran, C., Gaman, M. A., Ionescu, B., Tatic, A., Cirstea, M., … Stancioaica, M. C. (2024). Acute promyelocytic leukemia: Review of complications related to all-trans retinoic acid and arsenic trioxide therapy. Cancers, 16(6), 1160.

2. Mohorea‐Neata, A. L., Ghita, M. C., Moroti, R., Ghiaur, A., Ionescu, B., Tatic, A., … Stancioaica, M. C. (2023). Invasive fusariosis in acute leukaemia patients—An outbreak in the haematology ward. Mycoses, 66(8), 705–710.

3. Droc, G., Stancioaica, M. C., Soare, C. G., Stefan, M. G., Ingustu, D., Martac, C., … Ghiaur, A. (2023). Acute promyelocytic leukemia and severe differentiation syndrome in pregnancy—A management challenge. Life, 13(5), 1141.

4. Coriu, D., & Stancioaica, M. C. (2023). Moving low-risk myelodysplastic syndromes from humans to mice: Is it truly that simple? Haematologica, 109(1), 8.

5. Stancioaica, M. C., Coriu, D., & Ghiaur, G. (2025). FLT3: A 35-year voyage from discovery to the next generation of targeted therapy in AML. Cancers.

Chun-An Cheng | Translational Neuroscience | Lifetime achievement Award

Published on by Neuroscientists

Assist. Prof. Dr. Chun-An Cheng | Translational Neuroscience | Lifetime achievement Award

Assist. Prof. Dr. Chun-An Cheng | Tri-Service General Hospital | Taiwan

Assistant Professor Dr. Chun-An Cheng is a distinguished researcher affiliated with the Tri-Service General Hospital, Taiwan, known for his significant contributions to medical and clinical research. He has authored 73 scholarly documents, which have collectively garnered 658 citations across 620 publications, reflecting the wide impact and recognition of his scientific work. With an h-index of 14, Dr. Cheng has demonstrated consistent research productivity and influence within his field. His research encompasses multidisciplinary areas in clinical medicine, focusing on advancing diagnostic methodologies, therapeutic innovations, and patient-centered healthcare strategies. Through his collaborations and publications, Dr. Cheng has contributed to improving the understanding of complex medical conditions and enhancing evidence-based clinical practices. His dedication to translational research bridges the gap between laboratory findings and clinical applications, reinforcing his role as a key figure in the Taiwanese medical research community. Dr. Cheng continues to drive impactful studies that promote innovation, patient safety, and improved health outcomes, positioning him as a leading voice in contemporary clinical science.

Profiles: Scopus | Orcid | Research Gate

Featured Publications

  • (2025). Effects of exposure to air pollution and cold weather on acute myocardial infarction mortality. Atmosphere.

  • (2025). The risk of ischemic stroke in patients with chronic obstructive pulmonary disease and atrial fibrillation. Life.

  •  (2024). Increased risk of psychiatric disorder in patients with hearing loss: A nationwide population-based cohort study. Journal of Translational Medicine.

  • (2024). Diabetes mellitus and gynecological and inflammation disorders increased the risk of pregnancy loss in a population study. Life.

  • (2024). The influence of fine particulate matter and cold weather on emergency room interventions for childhood asthma. Life.

  • (2024). Impact of foodborne disease in Taiwan during the COVID-19 pandemic. Medicina (Lithuania).

  • (2024). Analyzing COVID-19 and air pollution effects on pediatric asthma emergency room visits in Taiwan. Toxics.

Tatsuya Yamasoba | Clinical Neuroscience | Best Researcher Award

Published on by Neuroscientists

Prof. Tatsuya Yamasoba | Clinical Neuroscience | Best Researcher Award

Prof. Tatsuya Yamasoba | University of Tokyo | Japan

Dr. Tatsuya Yamasoba is a Professor Emeritus at the University of Tokyo and Director of Tokyo Teishin Hospital, recognized internationally for his contributions to otology, neurotology, laryngology, and clinical neuroscience. He has published over 500 scientific papers in leading journals such as Science, Nature Chemistry, Nature Nanotechnology, Neuron, PNAS, and Neurology. His research focuses on regenerative medicine for sensorineural hearing loss, vestibular dysfunction, and dysphagia management in neurodegenerative diseases. With a citation index of over 24,150, an h-index of 75, and an i10-index of 353, his work has significantly advanced understanding and treatment of auditory and balance disorders. He has developed surgical techniques for severe hearing loss, pioneered galvanic vestibular stimulation therapy for disequilibrium, and improved aspiration prevention surgeries. Dr. Yamasoba has served as Editor-in-Chief of Auris Nasus Larynx and Associate Editor for ORL Journal and npj Aging and Mechanisms of Disease. He collaborates with leading research institutions including the University of Michigan and the University of California, Davis. His professional memberships include the International Federation of ORL Societies and the Asia Oceania Otorhinolaryngology and Head and Neck Society, reflecting his leadership and influence in advancing otolaryngology and auditory neuroscience globally.

Profile: Google Scholar

Featured Publications

Kujoth, G. C., Hiona, A., Pugh, T. D., Someya, S., Panzer, K., Wohlgemuth, S. E., et al. (2005). Mitochondrial DNA mutations, oxidative stress, and apoptosis in mammalian aging. Science, 309(5733), 481–484.

Tokunaga, T., Sakashita, M., Haruna, T., Asaka, D., Takeno, S., Ikeda, H., et al. (2015). Novel scoring system and algorithm for classifying chronic rhinosinusitis: The JESREC study. Allergy, 70(8), 995–1003.

Yamasoba, T., Lin, F. R., Someya, S., Kashio, A., Sakamoto, T., & Kondo, K. (2013). Current concepts in age-related hearing loss: Epidemiology and mechanistic pathways. Hearing Research, 303, 30–38.

Le Prell, C. G., Yamashita, D., Minami, S. B., Yamasoba, T., & Miller, J. M. (2007). Mechanisms of noise-induced hearing loss indicate multiple methods of prevention. Hearing Research, 226(1–2), 22–43.

Umezawa, K., Yoshida, M., Kamiya, M., Yamasoba, T., & Urano, Y. (2017). Rational design of reversible fluorescent probes for live-cell imaging and quantification of fast glutathione dynamics. Nature Chemistry, 9(3), 279–286.

Matsumoto, Y., Nichols, J. W., Toh, K., Nomoto, T., Cabral, H., Miura, Y., et al. (2016). Vascular bursts enhance permeability of tumour blood vessels and improve nanoparticle delivery. Nature Nanotechnology, 11(6), 533–538.

Iwasaki, S., & Yamasoba, T. (2014). Dizziness and imbalance in the elderly: Age-related decline in the vestibular system. Aging and Disease, 6(1), 38–47.

Someya, S., Xu, J., Kondo, K., Ding, D., Salvi, R. J., Yamasoba, T., Rabinovitch, P. S., et al. (2009). Age-related hearing loss in C57BL/6J mice is mediated by Bak-dependent mitochondrial apoptosis. Proceedings of the National Academy of Sciences, 106(46), 19432–19437.

Jane Paulsen | Clinical Neuroscience | Best Researcher Award

Published on by Neuroscientists

Prof. Dr. Jane Paulsen | Clinical Neuroscience | Best Researcher Award

Prof. Dr. Jane Paulsen | University of Wisconsin Madison | United States

Dr. Jane S. Paulsen, Ph.D., is a Professor of Neurology and Vice Chair for Research at the University of Wisconsin–Madison, where she also contributes to the Department of Neurosciences Graduate Program. Her expertise lies in cognitive, psychiatric, and imaging correlates of neuropsychiatric disorders, with a strong focus on the early detection of brain diseases and the development of innovative methods for clinical trials. She has significantly advanced the understanding of genetic discrimination and the discovery and validation of biological and clinical markers of brain disease, incorporating neuroimaging and omics-based outcomes into her research. Dr. Paulsen completed her Ph.D. in Counseling Psychology at the University of Iowa, followed by postdoctoral training in Neuropsychology at the University of California, San Diego, where she worked on Alzheimer’s and geriatric psychiatry research. Over her career, she has held key positions including Director of the Huntington’s Disease Clinical Research Program at UCSD and has contributed extensively to advancing neuropsychological research and clinical applications. Her scholarly impact includes 4 published documents, 78 citations from 77 documents, and an h-index of 3, reflecting her influence in the fields of neurology, neuropsychology, and cognitive neuroscience.

Profiles: Scopus | Google Scholar | Reserach Gate | linked In

Featured Publications

Sachdev, P. S., Blacker, D., Blazer, D. G., Ganguli, M., Jeste, D. V., Paulsen, J. S., & Petersen, R. C. (2014). Classifying neurocognitive disorders: The DSM-5 approach. Nature Reviews Neurology, 10(11), 634–642.

Ross, C. A., Aylward, E. H., Wild, E. J., Langbehn, D. R., Long, J. D., Warner, J. H., & Paulsen, J. S. (2014). Huntington disease: Natural history, biomarkers and prospects for therapeutics. Nature Reviews Neurology, 10(4), 204–216.

Paulsen, J. S., Langbehn, D. R., Stout, J. C., Aylward, E., Ross, C. A., Nance, M., & Shoulson, I. (2008). Detection of Huntington’s disease decades before diagnosis: The Predict-HD study. Journal of Neurology, Neurosurgery & Psychiatry, 79(8), 874–880.

Langbehn, D. R., Brinkman, R. R., Falush, D., Paulsen, J. S., Hayden, M. R., & International Huntington’s Disease Collaborative Group. (2004). A new model for prediction of the age of onset and penetrance for Huntington’s disease based on CAG length. Clinical Genetics, 65(4), 267–277.

Levy, M. L., Cummings, J. L., Fairbanks, L. A., Masterman, D., Miller, B. L., Craig, A. H., & Paulsen, J. S. (1998). Apathy is not depression. The Journal of Neuropsychiatry and Clinical Neurosciences, 10(3), 314–319.

Sachdev, P., Kalaria, R., O’Brien, J., Skoog, I., Alladi, S., Black, S. E., Blacker, D., & Paulsen, J. S. (2014). Diagnostic criteria for vascular cognitive disorders: A VASCOG statement. Alzheimer Disease & Associated Disorders, 28(3), 206–218.

Palmer, B. W., Heaton, R. K., Paulsen, J. S., Kuck, J., Braff, D., Harris, M. J., & Zisook, S. (1997). Is it possible to be schizophrenic yet neuropsychologically normal? Neuropsychology, 11(3), 437–446.

Plis, S. M., Hjelm, D. R., Salakhutdinov, R., Allen, E. A., Bockholt, H. J., Long, J. D., & Calhoun, V. D. (2014). Deep learning for neuroimaging: A validation study. Frontiers in Neuroscience, 8, 229.

Mohamed, S., Paulsen, J. S., O’Leary, D., Arndt, S., & Andreasen, N. (1999). Generalized cognitive deficits in schizophrenia: A study of first-episode patients. Archives of General Psychiatry, 56(8), 749–754.

Paulsen, J. S., Ready, R. E., Hamilton, J. M., Mega, M. S., & Cummings, J. L. (2001). Neuropsychiatric aspects of Huntington’s disease. Journal of Neurology, Neurosurgery & Psychiatry, 71(3), 310–314.

Li-Ru Zhao | Neurogenetics | Best Researcher Award

Published on by Neuroscientists

Prof. Dr. Li-Ru Zhao | Neurogenetics | Best Researcher Award

Dr. LR Zhao is a distinguished neuroscientist and professor at the State University of New York Upstate Medical University, with appointments in the Departments of Neurosurgery and Neuroscience & Physiology. He received his M.D. from Hebei Medical College and completed his Ph.D. at Lund University, focusing on neural stem cells, brain plasticity, and neurobiology. His postdoctoral work at the University of Minnesota explored the role of bone marrow stem cells in brain repair. Dr. Zhao’s research career spans multiple institutions, including Northwestern University and Louisiana State University Health Sciences Center, where he progressed from Research Assistant Professor to Associate Professor. His work primarily investigates mechanisms underlying brain repair and regeneration, with emphasis on traumatic brain injury, enriched environment interventions, and neurodegenerative diseases such as Alzheimer’s and CADASIL. He has successfully secured multiple NIH-funded grants, including R01 and R56 awards, totaling several million dollars, and has mentored numerous medical students through summer and research fellowship programs. Dr. Zhao has published 66 peer-reviewed documents, which have been cited 3,238 times by 2,814 documents, yielding an h-index of 27. His contributions have advanced understanding of hematopoietic growth factors in neurorepair, SCF+G-CSF-mediated recovery in chronic TBI, and the cellular mechanisms regulating neurodegeneration and regeneration, establishing him as a leader in translational neuroscience research.

Profiles: Scopus | Linked In

Featured Publications

  • Author(s). (2024). Research guideline recommendations for research on stem cells, human embryos, and gene editing.

  • Author(s). (2024). Hematopoietic growth factors regulate the entry of monocytes into the adult brain via chemokine receptor CCR5. International Journal of Molecular Sciences.

  • Author(s). (2024). Single-cell RNA sequencing reveals immunomodulatory effects of stem cell factor and granulocyte colony-stimulating factor treatment in the brains of aged APP/PS1 mice. Biomolecules.

  • Author(s). (2023). Stem cell factor and granulocyte colony-stimulating factor promote remyelination in the chronic phase of severe traumatic brain injury. Cells.

  • Author(s). (2021). SCF + G-CSF treatment in the chronic phase of severe TBI enhances axonal sprouting in the spinal cord and synaptic pruning in the hippocampus. Acta Neuropathologica Communications.

Ricardo Osorio | Clinical Neuroscience | Best Researcher Award

Published on by Neuroscientists

Dr. Ricardo Osorio | Clinical Neuroscience | Best Researcher Award

Dr. Ricardo S. Osorio is a tenured Associate Professor of Psychiatry and Radiology at NYU Grossman School of Medicine, where he directs the Healthy Brain Aging and Sleep Center and serves as Director of the Biomarker Core within the NYU Alzheimer’s Disease Research Center. A physician-scientist, Dr. Osorio investigates the interplay of sleep, vascular, and inflammatory mechanisms in Alzheimer’s disease, integrating multimodal biomarkers, neuroimaging, and detailed clinical phenotyping. He has led several landmark studies, including trials on sleep apnea, amyloid and tau accumulation, brain energetics, and locus coeruleus dysfunction, exploring how sleep and metabolic factors influence cognitive decline and neurodegeneration. His work has significantly advanced translational biomarker development, assay harmonization, and inclusive recruitment in aging research. Dr. Osorio has published over 130 peer-reviewed articles in top journals such as JAMA Neurology, Annals of Neurology, Sleep, Alzheimer’s & Dementia, Lancet, and Brain, contributing to more than 8,369 citing documents, with a total citation count of 9,893 and an h-index of 44. He serves on multiple editorial boards, including Sleep Medicine Reports, and has provided expert peer review for leading journals worldwide. His collaborative network spans the NYU Alzheimer’s Disease Research Center, Mount Sinai, the ENIGMA-Sleep Consortium, and numerous national and international aging and sleep research initiatives, mentoring the next generation of clinician-scientists while shaping the field of sleep and neurodegeneration.

Profiles: Scopus | Orcid | Google Scholar

Featured Publications

  1. Author(s). (Year). Disordered sleep and painful diabetic neuropathy (PDN): A review of the literature on pathophysiology, pharmacologic and nonpharmacologic treatment options, and future directions. Journal Name, Volume(Issue), pages.

  2. Author(s). (2025). EEG slow oscillations and overnight spatial navigational memory performance in CPAP-treated obstructive sleep apnea. Sleep, Volume(Issue), pages.

  3. Author(s). (2025). High-frequency oscillations >250 Hz in people with Down syndrome and associated Alzheimer’s disease dementia. Alzheimer’s & Dementia, Volume(Issue), pages.

  4. Author(s). (2025). Impact of Alzheimer’s disease on sleep in adults with Down syndrome. Alzheimer’s & Dementia, Volume(Issue), pages.

  5. Author(s). (2025). Sleep-wake variation in body temperature regulates tau secretion and correlates with CSF and plasma tau. Journal of Clinical Investigation, Volume(Issue), pages.

  6. Author(s). (2025). The stability of slow-wave sleep and EEG oscillations across two consecutive nights of laboratory polysomnography in cognitively normal older adults. Journal of Sleep Research, Volume(Issue), pages.

  7. Author(s). (2025). Two-year longitudinal outcomes of subjective cognitive decline in Hispanics compared to non-Hispanic Whites. Journal of Geriatric Psychiatry and Neurology, Volume(Issue), pages.

  8. Author(s). (Year). Enhancing sleep, wakefulness, and cognition with transcranial photobiomodulation: A systematic review. Journal Name, Volume(Issue), pages.

  9. Author(s). (2024). The relationship between anxiety and levels of Alzheimer’s disease plasma biomarkers. Journal of Alzheimer’s Disease, Volume(Issue), pages.

  10. Author(s). (2024). The neutrophil to lymphocyte ratio associates with markers of Alzheimer’s disease pathology in cognitively unimpaired elderly people. Immunity and Ageing, Volume(Issue), pages.

Zhou Yu | Behavioral Neuroscience | Best Researcher Award

Published on by Neuroscientists

Dr. Zhou Yu | Behavioral Neuroscience | Best Researcher Award

Dr. Yu Zhou is a postdoctoral researcher at Army Engineering University, specializing in the intersection of neuroscience, computer vision, and target detection. His research primarily focuses on deceptive visual design for both human and machine perception, exploring how visual stimuli can influence detection, recognition, and cognitive processing. Zhou has conducted pioneering studies on camouflage and optical deception, utilizing EEG-based brain functional network analysis to evaluate target visibility and cognitive responses. His work integrates principles from weapon science, biomedical engineering, and computer science to develop comprehensive models of visual perception and deception. Representative publications include investigations into neural responses to camouflage targets with varying exposure signs, the impact of color differences on brain activation patterns, and feasibility assessments of optical camouflage effects. Through these studies, he contributes to a deeper understanding of how visual designs can manipulate human attention and computer vision systems, providing actionable insights for defense technology applications. Zhou’s research emphasizes rigorous quantitative evaluation methods, leveraging neurophysiological data to inform the design of effective deceptive visual patterns. With an h-index of 2 and multiple citations, his work demonstrates a growing influence in fields spanning neuroscience-informed computer vision, perceptual deception, and applied optical camouflage.

Profiles: Scopus | Reasearch Gate

Featured publication

Author(s). (2024). Neural responses to camouflage targets with different exposure signs based on EEG. Neuropsychologia.